Exhibit 99.6

AIROBOTICS LTD.
Consolidated Statements of Financial Position

	As of June 30				As of December 31 2021
	2022		2021		As of December 31 2021
	Unaudited				Audited
	U.S. dollars in thousands
Current assets
Cash and cash equivalents	2,849		4,556		6,686
Restricted cash	57		60		62
Accounts receivables	356		122		250
Inventory	1,126		—		1,210
Other accounts receivables	307		652		393
	4,695		5,390		8,601
Non-current assets
Long-term deposits	46		32		34
Right-of-use-assets	508		777		674
Property and equipment, net	2,772		5,557		3,142
Intangible assets, net	15		39		26
	3,341		6,405		3,876
Total assets	8,036		11,795		12,477

Current liabilities
Accounts payables	85		447		312
Lease liability	309		310		328
Government grants liability	78		196		134
Convertible loans	—		13,282		—
Loan from related party	1,043		—		—
Other Payables	1,281		1,722		1,517
	2,796		15,957		2,291
Non-current liabilities
Government grants liability	1,528		1,352		1,348
Long-term lease liabilities	223		545		452
SAFE liability	—		4,497		—
	1,751		6,394		1,800
Total liabilities	4,547		22,351		4,091

Equity
Ordinary share capital	52		153		51
Share premium and reserves	150,331		119,949		149,094
Foreign currency translation reserve	(2	)	(3	)	(2	)
Accumulated deficit	(146,892	)	(130,655	)	(140,757	)
Total equity (deficiency)	3,489		(10,556	)	8,386
Total liabilities and equity	8,036		11,795		12,477

The attached Notes constitute an integral part of the interim consolidated financial statements.

September 22, 2022

Ron Stern

Meir Kliner

Yishay Curelaru

Financial statements approval date

Chairman

CEO and Director

CFO & COO

AIROBOTICS LTD.
Consolidated Statements of Comprehensive Income

	For the six months ended June 30			For the year ended on December 31 2021
	2022	2021		For the year ended on December 31 2021
	Unaudited			Audited
	U.S. dollars in thousands
Revenues (see Note 3)	544	1,646		3,287
Cost of revenues	1,299	2,225		3,661
Gross loss	755	579		374
Research and development expenses	2,103	4,255		7,702
Sales and marketing expenses	1,104	799		3,219
General and administrative expenses	1,646	2,787		6,033
Other expenses (income), net	287	(880	)	146
Operating loss	5,895	7,540		17,474
Financing expenses	330	1,141		1,383
Financing income	90	14		88
Loss for the period	6,135	8,667		18,769

Other comprehensive loss

Other comprehensive loss that may be reclassified to profit or loss in subsequent periods (net of tax):
Loss from exchange differences on translation of foreign operations	—	3		2
Loss from disposal of foreign operation	—	466		466
Total other comprehensive loss, net of tax	—	469		468
Total comprehensive loss	6,135	9,136		19,237

The attached Notes constitute an integral part of the interim consolidated financial statements.

AIROBOTICS LTD.
Consolidated Statements of Changes in Equity (Equity Deficit)

	Ordinary share capital	Share premium and reserves	Foreign currency translation reserve		Accumulated deficit		Total
	Unaudited
	U.S. dollars in thousands
Balance as of January 1, 2022	51	149,094	(2	)	(140,757	)	8,386
Loss for the period	—	—	—		(6,135	)	(6,135	)
Capital contribution from related party(*)	—	78	—		—		78
Exercise of options by employees	1	15	—		—		16
Share-based payments	—	1,144	—		—		1,144
Balance as of June 30, 2022	52	150,331	(2	)	(146,892	)	3,489

____________

(*) See Note 4 (d).

	Ordinary share capital	Share premium and reserves	Foreign currency translation reserve		Accumulated deficit		Total
	Unaudited
	U.S. dollars in thousands
Balance as of January 1, 2021	153	116,323	466		(121,988	)	(5,046	)
Loss for the period	—	—	—		(8,667	)	(8,667	)
Other comprehensive loss	—	—	(469	)	—		(469	)
Equity component in a convertible loan	—	183	—		—		183
Exercise of options by employees	—	3	—		—		3
Share-based payments	—	3,440	—		—		3,440
Balance as of June 30, 2021	153	119,949	(3	)	(130,655	)	(10,556	)

The attached Notes constitute an integral part of the interim consolidated financial statements.

AIROBOTICS LTD.
Consolidated Statements of Changes in Equity (Equity Deficit) — (Continued)

	Ordinary share capital		Share premium and reserves		Foreign currency translation reserve		Accumulated deficit		Total
	U.S. dollars in thousands
Balance as of January 1, 2021	153		116,323		466		(121,988	)	(5,046	)
Loss for the period	—		—		—		(18,769	)	(18,769	)
Other comprehensive loss	—		—		(468	)	—		(468	)
Exercise of options	1		34		—		—		35
Equity component in a convertible loan	—		217		—		—		217
Share-based payments	—		7,185		—		—		7,185
Conversion of convertible loan	775		14,123		—		—		14,898
Shareholders’ contribution to equity	—		3,436		—		—		3,436
Reduction of share par value	(896	)	896		—		—		—
Conversion of SAFE liability	8		4,464		—		—		4,472
Issuance of share capital, net of issuance costs	9		5,847		—		—		5,856
Issue costs related to conversion of convertible loan	—		(3,436	)	—		—		(3,436	)
Exercise of options	1		5		—		—		6
Balance as of December 31, 2021	51		149,094		(2	)	(140,757	)	8,386

The attached Notes constitute an integral part of the interim consolidated financial statements.

AIROBOTICS LTD.
Consolidated Statements of Cash Flow

	For the six months ended June 30				For the year ended on December 31 2021
	2022		2021		For the year ended on December 31 2021
	Unaudited				Audited
	U.S. dollars in thousands
Operating activities
Loss	(6,135	)	(8,667	)	(18,769	)

Adjustments to reconcile loss to net cash flows from operating activities
Depreciation and impairment of property and equipment and right-of-use assets	729		435		1,861
Amortization and impairment of intangible assets	11		18		32
(Gain) or loss on disposal or sale of property and equipment	26		(355	)	(292	)
Impairment of inventory	84		—		—
Share-based payments	1,144		3,440		7,185
Financing expenses, net	135		1,109		1,361
Revaluation of government grants	(37	)	(144	)	(203	)
Loan forgiveness guaranteed by the US government	—		(166	)	(166	)
Income from disposal of foreign operation	—		(466	)	(466	)
Remeasurement of options	—		—		38
	2,092		3,871		9,350
Changes in items of assets and liabilities:
Decrease (increase) in accounts receivable	(106	)	6		(122	)
Decrease (increase) in other accounts receivable	29		(373	)	(108	)
Increase (decrease) in accounts payable	(227	)	193		92
Increase (decrease) in other payables	(188	)	297		114
	(492	)	123		(24	)
Net cash used in operating activities	(4,535	)	(4,673	)	(9,443	)

Investing activities
Change in restricted cash, net	—		(11	)	(14	)
Investments in deposits	(6	)	(2	)	(4	)
Proceeds from sale of property and equipment	7		983		997
Purchase of property and equipment	(235	)	(334	)	(518	)
Net cash provided by (used in) investing activities	(234	)	636		461

Financing activities
Repayment of loans received	—		(833	)	(833	)
Proceeds from exercise of options, net	12		3		4
Payment of interest for loans and leases	(24	)	(38	)	(66	)
Payment of lease liability	(162	)	(155	)	(319	)
Loan from related party(*)	1,100		—		—
Proceeds from issuance of share capital, net	—		—		5,856
Proceeds from government grants	64		335		416
Payment of government grant royalties	(57	)	(12	)	(69	)
Proceeds from convertible loan	—		4,063		5,446
Proceeds from SAFE	—		4,455		4,455
Cash provided by financing activities	933		7,818		14,890
Exchange rate differences of cash balances and cash equivalents	(1	)	(5	)	(2	)
Net Increase (decrease) in cash and cash equivalents during the year	(3,837	)	3,776		5,906
Cash and cash equivalent at the beginning of the period	6,686		780		780
Cash and cash equivalent balance at the end of the period	2,849		4,556		6,686

AIROBOTICS LTD.
Consolidated Statements of Cash Flow — (Continued)

		For the six months ended June 30			For the year ended on December 31 2021
		2022		2021	For the year ended on December 31 2021
		Unaudited			Audited
		USD thousands
(a)	Significant non-cash transactions:
	Purchase of property and equipment on credit	14		34	—
	Right-of-use asset recognized with corresponding lease liability	(10	)	28	64
	Non-cash share issuance	3		—	6
	Conversion of convertible loan, SAFE & Warrant liability	—		—	19,402

The attached Notes constitute an integral part of the interim consolidated financial statements.

____________

(*) See Note 4(d).

AIROBOTICS LTD.
Notes to the Interim Consolidated Financial Statements

NOTE 1: General

a. Airobotics Ltd. (“Company”) was incorporated in Israel on August 5, 2014 and began operations on that date.

b. The Company collects, analyses, and provides access to information automatically using a UAV (“unmanned aerial vehicle”–multi-motor drone). The Company has developed systems that include data collection and data processing for valuable insights for customers, in an automated process, which does not require human contact and without human intervention, and provides its customers with end-to-end service, which enables the extraction of value from data collected from the airspace using an automated UAV, automatically, quickly, safely, and efficiently.

As of December 31, 2021, considering the expansion of the Company’s operations in the United Arab Emirates, the Company intend to sell the UAV equipment itself (a system that includes the docking station, 2 Drones and Mast), in addition to its service package as described above.

c. On September 22, 2021, the Company completed its initial public offering (IPO) on the Tel Aviv Stock Exchange Ltd. (“TASE”).

d. As of June 30, 2022 the Company has wholly-owned subsidiaries in the United States, Singapore and Dubai.

The Company’s subsidiary Airobotics Inc. was incorporated in the United States in 2016 and began operations during 2018. The subsidiary operates in sales, marketing and support of the Company’s products in the United States.

The subsidiary Airobotics PTE was incorporated in Singapore during the second quarter of 2019. As of the reporting date, the subsidiary has no sales and marketing activities.

The subsidiary Airobotics Gulf DMCC was incorporated in Dubai on March 8, 2022. The subsidiary will concentrate sales and marketing activities in the United Arab Emirates and the Persian Gulf countries.

e. These financial statements were prepared in a condensed form as of June 30, 2022 and for the six-month period that ended on that date (hereinafter: Interim Consolidated Financial Statements). These statements should be reviewed in connection with the Company’s annual financial statements as of December 31, 2021 and for the year that ended on that date and the notes accompanying them (hereinafter: the Annual Consolidated Financial Statements).

f. The Company has significant losses since its establishment. During the years the Company has financed its operations mainly through equity, convertible loans from shareholders; bank loans, and grants from the Israel Innovation Authority. The Company has negative cash flow from operating activities of $4,535 thousand, and a comprehensive loss of $6,135 thousand for the six-month period that ended on June 30, 2022, and an accumulated deficit of $146,892 thousand as of June 30, 2022. The Company has not yet signed a new contract with a material customer for 2022, a contract that the Company expected to be a significant part of its future growth. In addition, as of the reporting date, there are no signed orders from customers. The shareholder’s obligation to the Company, as noted in note 1 e (4) below depends on the agreement between the parties and as stated has not been fully realized through the date of approval of the financial statements.

The Company will be required to obtain additional financing in the short term in order to support its operation. The Company’s ability to successfully carry out its business plan is primarily dependent upon the continued financial support from its shareholders and its ability to raise sufficient additional capital. There are no assurances, however, that the Company will be successful in obtaining an adequate level of financing needed to support its operations.

AIROBOTICS LTD.
Notes to the Interim Consolidated Financial Statements

NOTE 1: General (cont.)

These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of assets or liabilities that might be necessary should the Company be unable to continue as a going concern.

The management’s plans include, among other things, the following:

1. On August 4, 2022, the Company entered into a binding merger agreement with Ondas, which is a public company traded on Nasdaq, for further information See also Note 5 (a).

2. Efficiency and improving profitability — during 2020 and 2021, the Company’s workforce was reduced. As a result, the salary expenses was reduced along with other operating expenses. in order to improve profitability and significantly reduce the operating loss. The Company will consider further reductions in the future, as necessary, if the Company’s plan in connection with the acquisition of the Company by the third party does not succeed, in a manner that does not harm the Company’s current activities and the Company’s ability to provide service to its customers.

3. Raising additional capital and debt — the Company will act to raise funds from additional sources in the form of capital and/or debt from existing and new shareholders and/or act to receive financing from external sources as needed.

4. On February 10, 2022, the Company received from a related party a letter of obligation to support the Company as needed, without limit of amount, for a period of at least 24 months from the date of the letter, through capital investment under terms to be agreed between the Company and the related party and pursuant to a board of directors’ resolution to be made. The Company and its legal counsels believe that the letter of obligation is considered a legal agreement that is binding on the re